| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 18, 2014Revenue of $4.4 Billion Grew 5% on Constant Currency Basis; 4% as Reported
MINNEAPOLIS - Nov. 18, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2015, which ended October 24, 2014. The company reported worldwide...
-
Aug 26, 2014Sapiens' Deep Brain Stimulation Technologies Strengthen Medtronic's Neuromodulation Portfolio and Neuroscience Leadership Position
MINNEAPOLIS and EINDHOVEN - Aug. 26, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has acquired Sapiens Steering Brain Stimulation (Sapiens SBS), a privately held developer of deep...
-
Aug 19, 2014Revenue of $4.3 Billion Grew 4% on Constant Currency Basis; 5% as Reported
MINNEAPOLIS - Aug. 19, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2015, which ended July 25, 2014. The company reported worldwide...
-
Mar 30, 2014Has Repaired Hearts of 6,000+ Patients; More Than Half Are Children
MINNEAPOLIS and WASHINGTON - March 30, 2014 - Medtronic, Inc. (NYSE: MDT), today announced the one-year results of the Melody® Transcatheter Pulmonary Valve (TPV) U.S. Post-Approval Study, which...
-
Dec 5, 2013
(Thomson Reuters ONE via COMTEX) --Activa® PC+S Deep Brain Stimulation System Enables Research Toward Personalized Treatment of Neurological and Psychological Diseases MINNEAPOLIS - December 5,...
-
Aug 7, 2013
(Thomson Reuters ONE via COMTEX) --First Implant of Activa® PC+S Deep Brain Stimulation System Initiates Research That Could One Day Significantly Change How Neurological and Psychological...
-
May 2, 2013
MINNEAPOLIS - May 2, 2013 - In keeping with its commitment to keep physicians informed about product performance and safety, Medtronic, Inc. (NYSE: MDT) issued an Urgent Medical Device Correction...
-
Mar 7, 2013IDE Submission for Symplicity HTN-4 Expands the Indicated Patient Population and Builds upon Medtronic's Rigorous Global Clinical Trial Program for Hypertension Treatment
MINNEAPOLIS - March 7, 2013 - Medtronic, Inc. (NYSE: MDT), announced today that the company has submitted an Investigational Device Exemption (IDE) to the U.S. Food and Drug Administration (FDA)...
-
Aug 21, 2012Revenue of $4.0 Billion Grew 5% on a Constant Currency Basis; 2% as Reported
MINNEAPOLIS - August 21, 2012 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2013, which ended July 27, 2012. The Company reported worldwide...
-
May 22, 2012Revenue of $4.3 Billion Grew 4% on a Constant Currency Basis; 3% as Reported
MINNEAPOLIS--(BUSINESS WIRE)--May. 22, 2012-- Medtronic, Inc. (NYSE:MDT) today announced financial results for its fourth quarter and fiscal year ended April 27, 2012. The company reported...
-
Mar 15, 2012Another Medtronic First in Neuromodulation in Canada
BRAMPTON, Ontario & MINNEAPOLIS--(BUSINESS WIRE)--Mar. 15, 2012-- Medtronic, Inc. (NYSE: MDT) today announced that it has received from Health Canada a license for Medtronic Deep Brain Stimulation...
-
Nov 20, 2011Revenue of $4.1 Billion Grew 3% on a Constant Currency Basis, 6% as Reported
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 22, 2011-- Medtronic, Inc. (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2012, which ended October 28, 2011. The company...
-
Aug 23, 2011Revenue of $4 Billion Driven by International Growth of 7% on a Constant Currency Basis; 19% as Reported
MINNEAPOLIS, Aug 23, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2012, which ended July 29, 2011. The Company...
-
Mar 16, 2011Single-Channel Device Completes Medtronic's Advanced Activa(R) Therapy Portfolio for Patients with Movement Disorders
MINNEAPOLIS, Mar 16, 2011 (BUSINESS WIRE) -- With the first U.S. implant of its new Activa SC neurostimulator for deep brain stimulation (DBS) therapy, Medtronic, Inc. (NYSE: MDT) today announced...
-
Nov 1, 2010
MINNEAPOLIS, Nov 18, 2010 (BUSINESS WIRE) -- Medtronic Inc. (NYSE: MDT), the leader in spinal cord stimulation for more than 25 years, today announced U.S. Food and Drug Administration (FDA)...
-
Sep 16, 2010Further Clinical Study Required for Application to U.S. Food and Drug Administration
MINNEAPOLIS, Sep 16, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the company has received CE (Conformité Européenne) Mark approval for Medtronic Deep Brain...
-
Jun 25, 2010Semi-Closed Loop System Designed to Reduce Severity and Duration of Hypoglycemia
MINNEAPOLIS, Jun 25, 2010 (BUSINESS WIRE) --Demonstrating its dedication to close the loop for diabetes management, Medtronic, Inc. (NYSE:MDT) today announced that the first patient has been...
-
Jun 2, 2010
MINNEAPOLIS, Jun 02, 2010 (BUSINESS WIRE) --In the largest, randomized, controlled study of deep brain stimulation (DBS) for Parkinson's disease, Medtronic DBS Therapy was shown to improve motor...
-
Mar 18, 2010
MINNEAPOLIS, Mar 18, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that a landmark publication highlighting results from the pivotal study for Medtronic Deep Brain Stimulation...
-
Mar 17, 2010Next Generation Integrated System - MiniMed Paradigm(R) REAL-Time Revel(TM) System - Incorporates Predictive Alerts to Help Patients More Tightly Control Diabetes
MINNEAPOLIS, Mar 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval for the MiniMed Paradigm(R) REAL-Time...
-
Mar 12, 2010
MINNEAPOLIS, Mar 12, 2010 (BUSINESS WIRE) -- The U.S. Food and Drug Administration (FDA) Neurological Devices Panel today voted seven to five to recommend approval with conditions of Deep Brain...
-
Mar 4, 2010
Company Recognized for Ground-Breaking Work in the Field of Deep Brain Stimulation Medtronic, Inc. (NYSE: MDT) today announced that it has been selected as one of Massachusetts Institute of Technology
-
Dec 6, 2009Ongoing Research Focuses on Optimizing DBS Therapy for Patients
MINNEAPOLIS--(BUSINESS WIRE)--Dec. 6, 2009-- Long-term data from an investigational study of Deep Brain Stimulation (DBS) Therapy for Epilepsy was released this week by Medtronic, Inc. (NYSE:MDT)...